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Radiation-based morphological and functional imagings,like radiology and nuclear medicine, are considered thestandard of care in modern medicine. Nuclear cardiologyis one of the most important domains of nuclearmedicine which has been playing an important role in thediagnosis, prognosis, and decision-making in clinicalcardiology. Myocardial perfusion imagings (MPIs), usingsingle-photon emission computerised tomography(SPECT) and positron emission tomography (PET), arethe most commonly performed nuclear cardiologyprocedures worldwide. Reasons for MPI's unprecedentedpopularity are its ability to study myocardial perfusionnon-invasively, precise estimation of left ventricularfunction, myocardial viability and risk stratification inpatients with known coronary artery disease (CAD) orafter myocardial infarction. Multigated acquisition(MUGA) imaging is considered as the modality of choicefor precise assessment of left ventricular ejectionfraction (LVEF) and volumes. But echocardiogram, beingthe major competitor, is leading far ahead in the clinicalpractice. Similarly, radionuclide first passed radionuclideangiogram (FPRA) is considered as the gold standardfor precise estimation of right ventricular ejection fraction(RVEF) and cardiac shunt quantification, but could notget popularity.
Over the last four decades, MPI has become a majornon-invasive tool for evaluation of CAD.1 However, thegreatest strength of MPI is due to its established role inrisk stratification in patients with known CAD or post-myocardial infarction.2 Precise assessment ofmyocardial blood flow (MBF), using PET or SPECTmethodology, has made MPI an indispensable tool forevaluation and management of CAD.3 The most popularindication of MPI is its role as the gatekeeper tocatheterisation laboratory for selection of the patientswho need invasive approach or would requireconservative management. Other important indicationsof MPI are the diagnosis of CAD in patients withintermediate pretest probability or asymptomaticpatients with abnormal ECG or symptomatic patient withnormal ECG. MPI is also indicated for assessment of
efficacy of therapeutic interventions like angioplasty orcoronary artery bypass graft (CABG) surgery, riskstratification, and preoperative cardiac assessment inintermediate to high risk patients. Quantification ofcoronary flow reserve (CFR), using PET or SPECT,provides an important piece of clinical information aboutthe hemodynamic significance of epicardial coronarylesion or diagnosis of small vessel disease.1 Recently,plaque imaging using PET-MPI has opened new avenuefor detection of vulnerable plaques, and targeted therapyof these plaque is expected to reduce CAD relatedmorbidity and mortality.4
Radiopharmaceuticals, which are used for MPI, includeTc-99m labelled Methoxy IsoButyl Isonitrile (MIBI),Tetrofosmin (MYOVIEW), BATO and NOET compounds.Last two agents have not yet approved for clinical use sofar. For assessment of the myocardial viability, Thallium-201 (Tl-201) is more sensitive and specific, as presenceof redistribution is a reliable indicator of intact cellmembrane and cell viability. However, due to its cost andsignificantly higher radiation exposure, various centresuse Tc-99m MIBI and MYOVIEW with sublingual nitrateaugmentation with reasonably good diagnostic accuracy.5
MPI is performed to assess the LV myocardial perfusionand function during stress and at rest. For stress part,dynamic exercise on treadmill or ergometer using Bruceor Modified Bruce protocol is a preferred choice as it ismore physiological and provides important informationabout the functional capacity like Metabolic Equivalent(METS), which has an established prognostic value forfuture cardiac events. For patients who are unable toperform exercise due to physical limitation or unreadableECGs like left bundle branch block (LBBB) or Wolffe-Parkinson-White (WPW) syndrome, vasodilator infusionlike adenosine, dipyridamole or regadenoson are thealternatives. However, these are not indicated if patienthas history of bronchospasm or asthma as these agentsmay induce severe bronchospasm (less likely withregadenoson). Vasodilator stress may be used with lowlevel exercise (hybrid protocol) as this modificationreduces the side effects like headache and hypotension;and also increases the sensitivity of test as well. Tc-99mMIBI or MYOVIEW are injected intravenously at peakstress and during resting status as these agentsdistribute according to regional perfusion status at thetime of injection and gets fixed into myocardium andprovides a snap-shot images of LV perfusion later on.Stress and rest MPIs may be performed on two separatedays (average 1.5 hour/day) or the same day (average
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3-4 hours). Gated SPECT images are acquired under agamma camera, which needs 15-20 minutes foracquisition of complete set of data. After reconstruction,images are analysed visually and semi-quantitativelyusing 17 segment model of American Heart Association(AHA) for assessment of LV perfusion, function, wallmotion abnormality and thickness.6
Based on MPI findings, patients are categorised as low(<1%), intermediate (1-3%), and high (>3%) risk groupsfor probability of annual major acute cardiac events(MACE) like fatal or non-fatal myocardial infarction. Anormal Gated MPI (GMPI) has a negative predictivevalue (NPV) of >99% with an established 0.4-0.6%annual incidence of MACE for exercise GMPI. However,NPV of vasodilator stress GMPI is relatively low ascompared to exercise GMPI.7 Various managementstrategies have been formulated based on perfusion andfunctional parameters like LVEF and end systolic volume(ESV) derived from GMPI. Patients with LVEF >50%,without or with mild to moderate perfusion defects,are considered low risk and deserve conservativemanagement; but those with LVEF 30-50% with mild tomoderate perfusion defects are considered intermediaterisk and are considered candidates for revascularisation.Patients with LVEF <30% are considered at high risk andsubjected to viability study with Thallium-201 or MIBI orMYOVIEW with nitrate augmentation to confirmpresence of hibernating myocardium. Presence orabsence of hibernating myocardium guides the treatingcardiologist about revascularisation or conservativemanagement, respectively. Similarly, patients with LVEF<45% and ESV <70 ml or LVEF < 45% and ESV >70 mlare considered to have lower and higher annualmortality rates, respectively.8
In recent years PET/CT has also stepped in from oncologyinto clinical cardiology domain. Being a hybrid imagingmodality, it provides information regarding perfusion,function, coronary artery calcium (CAC), coronaryanatomy, and precise estimation of CFR in one session.This one-stop-shop solution with lesser time and lesserradiation exposure are the real driving forces favouringthe robust growth of PET/CT MPI. However, availabilityof PET/CT facilities and its cost are the majorantagonistic factors.9
Over the last four decades, there has been a tremendousincrease in utilisation of SPECT-MPI all over the world.High sensitivity, non-invasiveness, and relatively easyavailability are the major factors responsible for thispositive worldwide trend. However, this trend has alsocontributed significantly high radiation exposure togeneral public. According to a report, radiation exposurefrom SPECT-MPI has increased from 1% to 10.5% oftotal exposure over the last 35 years to US population.Similarly, according to National Council for RadiationProtection and Management (NCRP), over the last 30
years there has been six-fold increase in radiationexposure to the American population.10 Stochasticeffects of radiation, like malignancy or genetic mutations,are the primary concerns which are unfortunately lessunderstood by medical community. To address theseissues, International Atomic Energy Agency (IAEA) hasintroduced strategy of justification and optimisation forradiation-based procedures. Similarly, American Societyof Nuclear Cardiology (ASNC) has introduced appropriateuse criteria (AUC) for MPI in an attempt to curtailunjustified MPIs contributing to radiation exposure togeneral public. Various professional societies of US andEurope have also released radiation dose reducingguidelines like use of stress-only protocol, use of lowdoses of radioisotope, use of more sensitive gammacameras, use of better reconstructive algorithm andpreference of PET-MPI over SPECT-MPI, whenavailable.1
MPI using SPECT or PET is the most sensitivefunctional imaging modality for precise assessment ofmyocardial perfusion and function. Being a non-invasivetool, it guides the cardiologists about the presence offunctionally significant CAD, selection of appropriatetreatment strategies, and most importantly riskstratification in patients with or without a major cardiacevent. SPECT-MPI has been used overwhelminglyworldwide in the last four decades, which has made itone of the major contributors of radiation exposure togeneral public. Stochastic effects, like cancer and geneticmutations, are the major concerns which areunfortunately less understood. To address this importantaspect, various strategies have been formulated byIAEA; and various appropriate use criteria have beenreleased by professional societies of the US andEurope. Recently, PET-MPI has been promoted overSPECT-MPI due to its higher sensitivity, diagnosticaccuracy, and absolute quantification of variousfunctional parameters in shorter time with significantlylower radiation exposures.
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